Mississippi House Bill HB932

Mississippi 2022 Regular Session

• Introduced: 1/17/22
• Refer: 1/17/22
• Failed: 2/1/22

Caption

Health insurance policies; require coverage for colorectal cancer screenings.

Impact

The implementation of HB 932 is expected to have a significant impact on state health policies, particularly in promoting preventative healthcare measures. By requiring insurance companies to cover annual colonoscopies and other screenings recommended by healthcare professionals, the bill aims to decrease the barriers that prevent individuals from accessing necessary medical examinations. This initiative is particularly vital for underserved populations who might otherwise forego critical health screenings due to cost concerns. The act reflects an understanding of the social determinants of health, aiming to uplift communities at a higher risk for colorectal cancer, especially those with limited access to healthcare services.

Summary

House Bill 932 aims to expand coverage for colorectal cancer screenings and diagnostic tests for individuals aged 45 and older, as well as those at high risk for developing colorectal cancer. The bill mandates that health insurance policies must provide comprehensive coverage for all colorectal examinations and laboratory tests without imposing excessive out-of-pocket expenses for the insured. This legislative move is in response to the alarming statistics regarding colorectal cancer, which has been identified as the second leading cause of cancer death in Mississippi. The bill underscores the importance of early detection and intervention in reducing mortality associated with this disease.

Contention

While the bill is poised to enhance cancer screening access, discussions around it may reveal varying viewpoints. Proponents argue that such preemptive measures could save lives and reduce long-term healthcare costs by catching cancer in its early, more treatable stages. Conversely, there may be concerns regarding the financial implications for insurance companies and the potential for increased premiums as a result of broader coverage mandates. Furthermore, some stakeholders may express skepticism about whether insurance companies will comply with new regulations without navigating loopholes or imposing hidden costs on policyholders.